Detection of silent myocardial ischemia in asymptomatic patients with diabetes: Results of a randomized trial and meta-analysis assessing the effectiveness of systematic screening

Trials

Volumn 12, Issue , 2011, Pages

  Lièvre, Michel M ^a   Moulin, Philippe ^a   Thivolet, Charles ^a   Rodier, Michel ^b   Rigalleau, Vincent ^c   Penfornis, Alfred ^d   Pradignac, Alain ^e   Ovize, Michel ^a  

^a UNIVERSITÉ LYON 1   (France)

^b DEPARTMENT OF NEUROLOGY   (France)

^c HAUT LÉVÊQUE HOSPITAL   (France)

^d UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^e HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIPYRIDAMOLE; DIAGNOSTIC AGENT; VASODILATOR AGENT;

ADULT; AGED; AMBULATORY CARE; ARTICLE; BICYCLE; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; DEATH; DIABETIC PATIENT; DISEASE SEVERITY; EMERGENCY CARE; EXERCISE TEST; FEMALE; FOLLOW UP; FRANCE; HEART FAILURE; HEART INFARCTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MORTALITY; MULTICENTER STUDY (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; OPEN STUDY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SCREENING; SILENT MYOCARDIAL ISCHEMIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STROKE; SURVIVAL RATE; ASYMPTOMATIC DISEASE; CAUSE OF DEATH; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; EMERGENCY HEALTH SERVICE; HEART MUSCLE ISCHEMIA; HOSPITAL; MASS SCREENING; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; SURVIVAL; TIME;

AGED; AMBULATORY CARE; ASYMPTOMATIC DISEASES; CAUSE OF DEATH; CHI-SQUARE DISTRIBUTION; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DIPYRIDAMOLE; EMERGENCY SERVICE, HOSPITAL; EXERCISE TEST; FEMALE; FRANCE; HEART FAILURE; HOSPITALIZATION; HOSPITALS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STROKE; SURVIVAL ANALYSIS; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VASODILATOR AGENTS;

EID: 79251559090     PISSN: 17456215     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-12-23     Document Type: Article

References (16)

1. Stamler J, Vaccaro O, Neaton J, Wentworth D, . for the multiple risk factor intervention trial research group Diabetes, other risk factors and 12 year cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 1993, 16:434-444. 10.2337/diacare.16.2.434, 8432214, for the multiple risk factor intervention trial research group.
2. Manson JE, Colditz GA, Stampfer MJ, et al. A prospective study of maturity onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 1991, 151:1141-1147. 10.1001/archinte.151.6.1141, 2043016.
3. Milan Study on Atherosclerosis and Diabetes (MISAD) group Prevalence of unrecognized silent myocardial ischemia and its association with atherosclerotic risk factors in non insulin dependent diabetes mellitus. Am J Cardiol 1997, 79:134-139. 10.1016/S0002-9149(96)00699-6, 9193011, Milan Study on Atherosclerosis and Diabetes (MISAD) group.
4. May O, Arilsen H, Damsgaard EM, Mickley H. Prevalence and prediction of silent ischemia in diabetes mellitus: a population based study. Cardiovasc Res 1997, 34:241-247. 10.1016/S0008-6363(97)00046-1, 9217896.
5. American Diabetes Association Consensus development conference on the diagnosis of coronary heart disease in people with diabetes. Diabetes Care 1998, 21:2231-2239. American Diabetes Association.
6. Puel J, Valensi P, Vanzetto G, et al. Identification of myocardial ischemia in the diabetic patient. Joint ALFEDIAM and SFC recommendations. Diabetes Metab 2004, 30:S3-S18.
7. Janand-Delenne B, Bory M, Savin B, Vague P, Habib G, Lassmann-Vague V. Silent myocardial ischemia in patients with diabetes. Diabetes Care 1999, 22:1396-1400. 10.2337/diacare.22.9.1396, 10480499.
8. Gazzaruso C, De Amici E, Garzaniti A, et al. Assessment of asymptomatic coronary artery disease in apparently uncomplicated type 2 diabetic patients. Diabetes Care 2002, 25:1418-1424. 10.2337/diacare.25.8.1418, 12145244.
9. Valensi P, Cosson E, Pariès J, et al. Predictive value of silent myocardial ischemia for cardiac events in diabetic patients. Influence of age in a French multicentre study. Diabetes Care 2005, 28:2722-27. 10.2337/diacare.28.11.2722, 16249546.
10. Katritsis DG, Ioannidis JPA. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease. A meta-analysis. Circulation 2005, 111:2906-2912. 10.1161/CIRCULATIONAHA.104.521864, 15927966.
11. Recommandations de la Société Française de Cardiologie concernant la pratique des épreuves d'effort chez l'adulte en cardiologie. Arch Mal Coeur Vaiss 1997, 90:77-91.
12. Normand SL. Meta-analysis: formulating, evaluating, combining, and reporting. Stat Med 1999, 18:321-59. 10.1002/(SICI)1097-0258(19990215)18:3<321::AID-SIM28>3.0.CO;2-P, 10070677.
13. EasyMA.net Plate-forme de conception et de réalisation de méta-analyses d'essais thérapeutiques. EasyMA.net., http://www.spc.univ-lyon1.fr/easyma.net/
14. Young LH, Wackers F, Cyun DA, et al. for the DIAD investigators Detection of silent myocardial ischemia in asymptomatic diabetic subjects. The DIAD study. JAMA 2009, 301:1547-1555. 10.1001/jama.2009.476, 2895332, 19366774, for the DIAD investigators.
15. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, et al. COURAGE Trial Research Group Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007, 356:1503-1516. 10.1056/NEJMoa070829, 17387127, COURAGE Trial Research Group.
16. The BARI 2D study group A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 2009, 360:2503-2515. Cardiac Outcomes After Screening for Asymptomatic Coronary Artery Disease in Patients With Type 2 Diabetes The DIAD Study: A Randomized Controlled Trial, 10.1056/NEJMoa0805796, 2863990, 19502645, The BARI 2D study group.